Skip to main content
Stephanie (Downey) Goff, MD, General Surgery, New York, NY

StephanieLynn(Downey)GoffMDFACS

General Surgery New York, NY

Breast, Melanoma, Surgical Oncology (Other than Breast)

Staff Clinician, Surgery Branch, National Cancer Institute

Dr. Goff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goff's full profile

Already have an account?

  • Office

    177 Fort Washington Ave
    MHB 7GS 313
    New York, NY 10032
    Phone+1 813-787-4286

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
  • Massachusetts General Hospital
    Massachusetts General HospitalFellowship, Complex General Surgical Oncology, 2012 - 2014
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Surgery, 2009 - 2012
  • National Cancer Institute
    National Cancer InstituteFellowship, Tumor Immunology, 2005 - 2009
  • New York Medical College at St Vincent's Hospital and Medical Center of New York
    New York Medical College at St Vincent's Hospital and Medical Center of New YorkInternship, Surgery, 2003 - 2005
  • University of South Florida College of Medicine
    University of South Florida College of MedicineClass of 2003

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 2005 - 2025
  • MA State Medical License
    MA State Medical License 2012 - 2018
  • American Board of Surgery Surgery

Publications & Presentations

PubMed

Lectures

  • Is There a Role for Adoptive Cell Therapy in the Treatment of Melanoma? 
    2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018

Press Mentions

  • Understanding the Risk of Second Cancers After CAR T-cell Therapy
    Understanding the Risk of Second Cancers After CAR T-cell TherapyAugust 13th, 2024
  • Evidence Mounting for TILs as Possible First-Line Cancer Therapy
    Evidence Mounting for TILs as Possible First-Line Cancer TherapySeptember 24th, 2021
  • Adoptive Transfer of Tumor-Infiltrating Lymphocytes May Be Less Effective in Patients with Pretreated Metastatic Melanoma
    Adoptive Transfer of Tumor-Infiltrating Lymphocytes May Be Less Effective in Patients with Pretreated Metastatic MelanomaAugust 18th, 2021
  • Join now to see all